Lipocine
Manufacturing · Utah, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
675 S Arapeen Dr Ste 202, Salt Lake City...Phone Number
(801) 994-7383Website
www.lipocine.comRevenue
<$5 MillionStock Symbol
LPCNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Lipocine
Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for CNS disorders. Lipocine has drug candidates in development as well as drug candidates for which we are exploring partnering. Our drug candidates represent enablement of differentiated, patient friendly oral delivery options for favorable benefit to risk profile which target large addressable markets with significant unmet medical needs.Explore more
Lipocine Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Lipocine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Lipocine launches new products
Earning: See what the market has to say on Lipocine recently announced quarterly report
Check out if Lipocine is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Lipocine has recently received funding, and reach out quickly before it becomes old news!
Lipocine, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Lipocine had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Lipocine has new funding data
Congratulate Masked Content for being promoted to Masked Content at Lipocine
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Lipocine
Compare insights from companies similar to Lipocine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Lipocine is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Lipocine is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Lipocine.
Lipocine financials insights
Gather financial insights about Lipocine, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Stock Offering
$38M
2020
Debt
$150K
Lipocine Tech Stack
A closer look at the technologies used by Lipocine
See more technologies
Most Recent Scoops
Project
Lipocine has completed formulation screening, dose-finding, and dosing regimen confirmation studies for its postpartum depression treatment, and is conducting a Phase 3 trial with approximately 80 women, aiming for an NDA submission in mid-2026 pending positive results.
Medical Research, Pharmaceuticals, Clinical Operations
Project
believes its LPC and illerand-futero treatment could be a first-line option for postpartum depression, given its short treatment duration, expected robust efficacy, and good tolerability. The company estimates a potential 30% to 50% market share, with analysts approximating the U.S. market size between $500 million to $1 billion.
Research & Development, Financial Planning, Pharmaceuticals, Finance, Financial Strategy
Project
Lipocine is developing 2401 as an adjunct to GLP-1 treatments to improve and potentially amplify weight and fat loss. The treatment aims to maintain or improve GLP-1 related weight loss and add to the fat loss observed in phase 2 results.
Product Development, Research & Development, Pharmaceuticals
Project
Lipocine is developing 24-1 to address shortcomings of GLP-1 treatments while maintaining their benefits. The treatment aims to improve body composition and weight loss without compromising GLP-1 effects or adding tolerability issues.
Product Development, Research & Development, Pharmaceuticals
Project
Product Development, Research & Development, Pharmaceuticals
Lipocine News & Media
Lipocine to Present at A.G.P.'s Annual Virtual Healthcare Company Showcase
SALT LAKE CITY, May 18, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced that management will participate in a fireside chat at A.G.P.'s...Lipocine Announces Financial Results for the First Quarter Ended March 31, 2026
SALT LAKE CITY, May 7, 2026 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery, today announced financial results for the first quarter ended March 31, 2026 and...Lipocine Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
SAN DIEGO, April 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Lipocine Inc. (NASDAQ: LPCN). The investigation focuses on Lipocine’s executive officers and whether investor losses may be recovered under federal securities laws.Lipocine Reports Topline Safety and Efficacy Results for LPCN 1154 in Patients with Postpartum Depression
In the Phase 3 study population (N=90) of patients with PPD, LPCN 1154 did not show a statistically significant reduction from baseline in HAM-D17 total score compared to placebo at hour 60 (primary endpoint); the primary endpoint was not met In a post hoc analysis of participants (n=54)...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lipocine
Sign Up For FreeTo access detailed company insights
Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to augment therapeutics through effective oral delivery to develop differentiated products for CNS disorders. Lipocine has drug candidates in development as well as drug candidates for which we are exploring partnering. Our drug candidates represent enablement of... Read More
